nvs
☆    

India,
2008-02-19 08:11
(5909 d 01:06 ago)

(edited by Ohlbe on 2008-02-19 21:46)
Posting: # 1621
Views: 3,009
 

 Type of studies etc. [Dissolution / BCS / IVIVC]

Dear all,
Anybody let me know about flow for in-vitro studies, In which stage of drug designing we have to take approval for in-vitro studies for both innovative & generic drugs.
Which parameters we have to do?
Do we conduct in-vitro studies separately with different mechanism (different in-vitro parameters) for generic & innovative drugs.
What are the common parameters for generic & innovative drugs (in in-vitro studies)
pz share any guidelines regarding this.

--
Edit: Category changed. [Ohlbe]
Edit: Subject line altered. [Helmut]
UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,659 registered users;
64 visitors (0 registered, 64 guests [including 7 identified bots]).
Forum time: 10:18 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5